CSLLY
Price
$82.82
Change
+$0.82 (+1.00%)
Updated
Mar 7 closing price
Capitalization
77.9B
RXRX
Price
$6.13
Change
-$0.47 (-7.13%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
2.65B
57 days until earnings call
Ad is loading...

CSLLY vs RXRX

Header iconCSLLY vs RXRX Comparison
Open Charts CSLLY vs RXRXBanner chart's image
CSL
Price$82.82
Change+$0.82 (+1.00%)
Volume$43.13K
Capitalization77.9B
Recursion Pharmaceuticals
Price$6.13
Change-$0.47 (-7.13%)
Volume$173.3K
Capitalization2.65B
CSLLY vs RXRX Comparison Chart
Loading...
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSLLY vs. RXRX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSLLY is a StrongBuy and RXRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (CSLLY: $82.82 vs. RXRX: $6.59)
Brand notoriety: CSLLY and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSLLY: 51% vs. RXRX: 74%
Market capitalization -- CSLLY: $77.9B vs. RXRX: $2.65B
CSLLY [@Biotechnology] is valued at $77.9B. RXRX’s [@Biotechnology] market capitalization is $2.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSLLY’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • CSLLY’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than CSLLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSLLY’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • CSLLY’s TA Score: 6 bullish, 2 bearish.
  • RXRX’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, CSLLY is a better buy in the short-term than RXRX.

Price Growth

CSLLY (@Biotechnology) experienced а +1.79% price change this week, while RXRX (@Biotechnology) price change was -12.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

RXRX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSLLY($77.9B) has a higher market cap than RXRX($2.65B). RXRX YTD gains are higher at: -2.515 vs. CSLLY (-5.413). CSLLY has higher annual earnings (EBITDA): 4.73B vs. RXRX (-350.86M). CSLLY has more cash in the bank: 885M vs. RXRX (428M). RXRX has less debt than CSLLY: RXRX (90.6M) vs CSLLY (12.2B). CSLLY has higher revenues than RXRX: CSLLY (14.7B) vs RXRX (64.6M).
CSLLYRXRXCSLLY / RXRX
Capitalization77.9B2.65B2,941%
EBITDA4.73B-350.86M-1,349%
Gain YTD-5.413-2.515215%
P/E Ratio29.13N/A-
Revenue14.7B64.6M22,755%
Total Cash885M428M207%
Total Debt12.2B90.6M13,466%
FUNDAMENTALS RATINGS
CSLLY: Fundamental Ratings
CSLLY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
74
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSLLYRXRX
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
50%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bullish Trend 4 days ago
46%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
59%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
50%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
52%
Bullish Trend 20 days ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
64%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
54%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bearish Trend 4 days ago
57%
Bullish Trend 4 days ago
89%
View a ticker or compare two or three
Ad is loading...
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IPAYX10.980.15
+1.39%
Integrity Dividend Summit I
FLAPX18.440.13
+0.71%
Fidelity Flex Mid Cap Index
IVGIX22.260.08
+0.36%
VY® Invesco Growth and Income I
ATHDX26.690.08
+0.30%
American Century Heritage R6
PGWAX81.670.05
+0.06%
Virtus Silvant Focused Growth A

CSLLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSLLY has been loosely correlated with ADPT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CSLLY jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSLLY
1D Price
Change %
CSLLY100%
+1.00%
ADPT - CSLLY
34%
Loosely correlated
-5.41%
RXRX - CSLLY
34%
Loosely correlated
+5.61%
VIR - CSLLY
33%
Poorly correlated
-1.36%
FOLD - CSLLY
33%
Poorly correlated
-1.77%
CDXS - CSLLY
33%
Poorly correlated
+3.30%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+5.61%
CRSP - RXRX
66%
Closely correlated
+5.13%
BEAM - RXRX
61%
Loosely correlated
+4.51%
PRME - RXRX
56%
Loosely correlated
+4.35%
NTLA - RXRX
56%
Loosely correlated
+4.55%
ABSI - RXRX
53%
Loosely correlated
+0.65%
More